Skip to main content
. 2010 Jan 18;78(1):103–115. doi: 10.3797/scipharm.0909-08

Tab.1.

Anti-ulcer activity of various formulations in rats (n=5, dose eqv. ∼10 mg/kg of drug)

Group Ulcer Indexa
CMC (Control) 0.5 ± 1.02
ETD 5.0 ± 2.11
PM1 2.0 ± 2.17
KD1 1.0 ± 1.23
KD2 1.0 ± 1.44
SD 1.5 ± 1.09
a

Data represent mean ± S.D.